305 related articles for article (PubMed ID: 22407312)
61. MiR-371-5p facilitates pancreatic cancer cell proliferation and decreases patient survival.
He D; Miao H; Xu Y; Xiong L; Wang Y; Xiang H; Zhang H; Zhang Z
PLoS One; 2014; 9(11):e112930. PubMed ID: 25411783
[TBL] [Abstract][Full Text] [Related]
62. Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth.
Takahashi N; Fukushima T; Yorita K; Tanaka H; Chijiiwa K; Kataoka H
Int J Cancer; 2010 Apr; 126(7):1611-20. PubMed ID: 19711349
[TBL] [Abstract][Full Text] [Related]
63. Restoration of E-cadherin expression in pancreatic ductal adenocarcinoma treated with microRNA-101.
Qazi AM; Gruzdyn O; Semaan A; Seward S; Chamala S; Dhulipala V; Sethi S; Ali-Fehmi R; Philip PA; Bouwman DL; Weaver DW; Gruber SA; Batchu RB
Surgery; 2012 Oct; 152(4):704-11; discussion 711-3. PubMed ID: 22943841
[TBL] [Abstract][Full Text] [Related]
64. miR‑96 functions as a tumor suppressor gene by targeting NUAK1 in pancreatic cancer.
Huang X; Lv W; Zhang JH; Lu DL
Int J Mol Med; 2014 Dec; 34(6):1599-605. PubMed ID: 25242509
[TBL] [Abstract][Full Text] [Related]
65. Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers.
Tavano F; di Mola FF; Piepoli A; Panza A; Copetti M; Burbaci FP; Latiano T; Pellegrini F; Maiello E; Andriulli A; di Sebastiano P
Pancreas; 2012 Nov; 41(8):1280-4. PubMed ID: 22836856
[TBL] [Abstract][Full Text] [Related]
66. Megakaryocytic differentiation of CD133+ hematopoietic stem cells by down-regulation of microRNA-10a.
Zarif MN; Soleimani M; Abolghasemi H; Amirizade N; Arefian E; Rahimian A
Hematology; 2013 Mar; 18(2):93-100. PubMed ID: 23321646
[TBL] [Abstract][Full Text] [Related]
67. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition.
Wang C; Yin W; Liu H
J Cell Biochem; 2020 Nov; 121(11):4505-4521. PubMed ID: 32542845
[TBL] [Abstract][Full Text] [Related]
68. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival.
Greither T; Grochola LF; Udelnow A; Lautenschläger C; Würl P; Taubert H
Int J Cancer; 2010 Jan; 126(1):73-80. PubMed ID: 19551852
[TBL] [Abstract][Full Text] [Related]
69. The role of miR-21 and miR-211 on MMP9 regulation in pancreatic ductal adenocarcinoma: cooperation in invasiveness behaviors?
Funel N
Epigenomics; 2015; 7(3):333-5. PubMed ID: 26077422
[No Abstract] [Full Text] [Related]
70. Expression profiling identifies microRNA signature in pancreatic cancer.
Lee EJ; Gusev Y; Jiang J; Nuovo GJ; Lerner MR; Frankel WL; Morgan DL; Postier RG; Brackett DJ; Schmittgen TD
Int J Cancer; 2007 Mar; 120(5):1046-54. PubMed ID: 17149698
[TBL] [Abstract][Full Text] [Related]
71. Kindlin-1 expression is involved in migration and invasion of pancreatic cancer.
Mahawithitwong P; Ohuchida K; Ikenaga N; Fujita H; Zhao M; Kozono S; Shindo K; Ohtsuka T; Aishima S; Mizumoto K; Tanaka M
Int J Oncol; 2013 Apr; 42(4):1360-6. PubMed ID: 23440354
[TBL] [Abstract][Full Text] [Related]
72. Enhanced phosphorylation of p53 by microRNA-26a leading to growth inhibition of pancreatic cancer.
Batchu RB; Gruzdyn OV; Qazi AM; Kaur J; Mahmud EM; Weaver DW; Gruber SA
Surgery; 2015 Oct; 158(4):981-6; discussion 986-7. PubMed ID: 26189069
[TBL] [Abstract][Full Text] [Related]
73. MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer.
Kanno S; Nosho K; Ishigami K; Yamamoto I; Koide H; Kurihara H; Mitsuhashi K; Shitani M; Motoya M; Sasaki S; Tanuma T; Maguchi H; Hasegawa T; Kimura Y; Takemasa I; Shinomura Y; Nakase H
Carcinogenesis; 2017 Apr; 38(4):425-431. PubMed ID: 28186267
[TBL] [Abstract][Full Text] [Related]
74. Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model.
Rachagani S; Macha MA; Menning MS; Dey P; Pai P; Smith LM; Mo YY; Batra SK
Oncotarget; 2015 Nov; 6(37):40295-309. PubMed ID: 26516699
[TBL] [Abstract][Full Text] [Related]
75. Expression and functional perspectives of miR-184 in pancreatic ductal adenocarcinoma.
Li H; Xiang H; Ge W; Wang H; Wang T; Xiong M
Int J Clin Exp Pathol; 2015; 8(10):12313-8. PubMed ID: 26722418
[TBL] [Abstract][Full Text] [Related]
76. EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas.
Mees ST; Mardin WA; Wendel C; Baeumer N; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Int J Cancer; 2010 Jan; 126(1):114-24. PubMed ID: 19569050
[TBL] [Abstract][Full Text] [Related]
77. Identification of androgen-responsive microRNAs and androgen-related genes in breast cancer.
Nakano K; Miki Y; Hata S; Ebata A; Takagi K; McNamara KM; Sakurai M; Masuda M; Hirakawa H; Ishida T; Suzuki T; Ohuchi N; Sasano H
Anticancer Res; 2013 Nov; 33(11):4811-9. PubMed ID: 24222117
[TBL] [Abstract][Full Text] [Related]
78. MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer.
Khan S; Ebeling MC; Zaman MS; Sikander M; Yallapu MM; Chauhan N; Yacoubian AM; Behrman SW; Zafar N; Kumar D; Thompson PA; Jaggi M; Chauhan SC
Oncotarget; 2014 Sep; 5(17):7599-609. PubMed ID: 25277192
[TBL] [Abstract][Full Text] [Related]
79. MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms.
Dumas PY; Mansier O; Prouzet-Mauleon V; Koya J; Villacreces A; Brunet de la Grange P; Luque Paz D; Bidet A; Pasquet JM; Praloran V; Salin F; Kurokawa M; Mahon FX; Cardinaud B; Lippert E
BMC Cancer; 2018 Nov; 18(1):1098. PubMed ID: 30419846
[TBL] [Abstract][Full Text] [Related]
80. Global microRNA profiling of pancreatic neuroendocrine neoplasias.
Thorns C; Schurmann C; Gebauer N; Wallaschofski H; Kümpers C; Bernard V; Feller AC; Keck T; Habermann JK; Begum N; Lehnert H; Brabant G
Anticancer Res; 2014 May; 34(5):2249-54. PubMed ID: 24778027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
